Abdulla A. Damluji/Linkedin
Aug 12, 2025, 20:14
JACC Meta-Analysis: Anticoagulant Therapy for Atrial Fibrillation Patients Surviving Intracranial Hemorrhage
Abdulla A. Damluji, Director of the Cardiovascular Center on Aging at Cleveland Clinic, has shared a post on X:
“Anticoagulants for Atrial Fibrillation in Survivors of Intracranial Hemorrhage: A Meta-Analysis of Randomized Trials: JACCJournals.
New publication from our HeartWise research Group led by friend: Michael Nanna in JACC today!”
Read the full article here.
Title: Anticoagulants for Atrial Fibrillation in Survivors of Intracranial Hemorrhage
Authors: Kuan-Yu Chi, Yu Chang, Pei-Lun Lee, Raiza Rossi, Yu-Shiuan Lin, Zafer Akman, Dimitrios Varrias, Abdulla A. Damluji, and Michael G. Nanna
Stay updated on the latest scientific advances in the field of bleeding disorders with Hemostasis Today.
-
Jan 9, 2026, 07:38Bartosz Hudzik on Subacute Coronary Occlusions: Navigating the Gray Zone in CAD Care
-
Jan 9, 2026, 07:27Gregory Piazza on The Role of D-Dimer in VTE Evaluation
-
Jan 9, 2026, 07:19Emmanuel J Favaloro Shares the 1st Article in a VWD Series Marking the 100-Year Anniversary
-
Jan 9, 2026, 07:07Taylor Robichaux on Recombinant ADAMTS13 Therapy in cTTP
-
Jan 9, 2026, 06:25Sara Ng: VTE Continues to Plague Modern Oncology
-
Jan 9, 2026, 06:12James Caldwell on The Hidden Culprit in Perimesencephalic SAH
-
Jan 8, 2026, 05:51Dominika Jędrzejewska Akbaş Links Sleep Deprivation, Obesity, and Stroke
-
Jan 8, 2026, 05:42Rob Maloney: A Bruise that Did Not Go Away…
-
Jan 8, 2026, 05:33Matías J Alet on Treating Early Neurological Deterioration in Lacunar Stroke